CNOT6L and type 2 diabetes mellitus: Additionally, this study found that CNOT6L interacts with miRNAs such as hsa-miR-106b-5p, hsa-miR-186-5p, hsa-miR-146a-5p; hsa-miR-17-5p, hsa-miR-18a-5p, hsa-miR-19a-3p, suggesting that CNOT6L may influence the activity of signaling pathways associated with type 2 diabetes by regulating the stability of these miRNAs, among other factors, thereby impacting disease progression.